Drug Patent Expirations for Dec 17, 2015

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

NORDITROPIN NORDIFLEX (somatropin recombinant)
Novo Nordisk Inc
Patent number: 5,849,700
Expiration Date: Dec 15, 2015


NORDITROPIN (somatropin recombinant)
Novo Nordisk Inc
Patent number: 5,849,704
Expiration Date: Dec 15, 2015


NORDITROPIN FLEXPRO (somatropin recombinant)
Novo Nordisk Inc
Patent number: 5,849,704
Expiration Date: Dec 15, 2015


NORDITROPIN NORDIFLEX (somatropin recombinant)
Novo Nordisk Inc
Patent number: 5,849,704
Expiration Date: Dec 15, 2015


NORDITROPIN (somatropin recombinant)
Novo Nordisk Inc
Patent number: 5,849,700
Expiration Date: Dec 15, 2015


NORDITROPIN FLEXPRO (somatropin recombinant)
Novo Nordisk Inc
Patent number: 5,849,700
Expiration Date: Dec 15, 2015


BUTRANS (buprenorphine)
Purdue Pharma Lp
Patent number: 6,264,980
Expiration Date: Dec 18, 2015


BUTRANS (buprenorphine)
Purdue Pharma Lp
Patent number: 6,344,211
Expiration Date: Dec 18, 2015


UCERIS (budesonide)
Valeant Pharms Intl
Patent number: 5,914,122
Expiration Date: Dec 19, 2015


FEMRING (estradiol acetate)
Warner Ireland
Patent number: 5,855,906
Expiration Date: Dec 19, 2015


For more information try a free trial

Click here for reuse options!
Copyright 2015 Biotechblog

Leave a Reply

%d bloggers like this: